Related Experiment Video
Updated: Feb 9, 2026

Deep Brain Stimulation with Simultaneous fMRI in Rodents
Published on: February 15, 2014
Recent advances in deep brain stimulation in psychiatric disorders
Anne-Hélène Clair1, William Haynes1,2, Luc Mallet1,3
1Sorbonne University, UPMC Paris 06 University, INSERM, CNRS, Institut du Cerveau et de la Moelle épinière, Paris, France.
Deep brain stimulation (DBS) shows promise for Obsessive Compulsive Disorder and Tourette Syndrome, improving symptoms and quality of life. However, its efficacy for Major Depression remains unproven, necessitating further clinical trials for psychiatric disorders.
Area of Science:
- Neurosurgery
- Psychiatry
- Neuroscience
Background:
- Deep brain stimulation (DBS) is a neuromodulation technique used for severe, treatment-resistant neuropsychiatric disorders.
- Key targets involve the cortico-striato-thalamo-cortical circuits, influencing symptom severity.
Purpose of the Study:
- To review recent clinical outcomes of DBS in psychiatric disorders.
- To assess the efficacy and ongoing research directions for DBS in conditions like OCD, TS, MDD, anorexia nervosa, and addiction.
Main Methods:
- Review of recent clinical studies and outcomes.
- Analysis of long-term effects, adjuvant therapies, and randomized controlled trials.
Main Results:
- DBS shows encouraging long-term results for Obsessive Compulsive Disorder (OCD) and Gilles de la Tourette Syndrome (TS), improving symptoms and quality of life.
- Adjuvant therapies like cognitive behavioral therapy enhance DBS response in OCD and TS.
- Large randomized studies have not demonstrated DBS efficacy for Major Depressive Disorder (MDD) based on evidence-based criteria.
- Preliminary results for anorexia nervosa and addiction are encouraging.
- No current DBS target meets international criteria for clinical efficacy in psychiatric disorders.
Conclusions:
- DBS remains a promising but investigational treatment for severe neuropsychiatric disorders.
- Further research and clinical trials are essential to establish efficacy and define optimal targets.
- DBS efficacy varies significantly across different psychiatric conditions, with stronger evidence for OCD and TS than MDD.
Related Concept Videos
Intrinsically Disordered Proteins
Overview of Advanced Functional Groups
Functional groups are groups of atoms with specific chemical properties that occur within organic molecules and are sometimes denoted as “R”. Functional groups can “functionalize” a compound by enabling it to adopt different physical and chemical properties.
Types of Advanced Functional Groups
The table below summarizes some of the major functional groups in organic chemistry.
Extraction: Advanced Methods
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...

